
Keywords: Breast cancer; Lobular carcinoma in situ; Gene expression; Risk factor; PrecursorLCIS, lobular carcinoma in situ; ILC, invasive lobular carcinoma; ER, estrogen receptor; MSKCC, Memorial Sloan Kettering Cancer Center; H&E, hematoxylin and eosin; LCM, laser